To procure support services of a biologist who is familiar with EIB's research and who can: independently conduct experiments, present results, participate in weekly discussions
Ended Awarded Last action
- Contract number
- 75N91022F00012
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $97,175
Award facts
- Contract value 100% obligated
- $97,175.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award from the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to Astrix Technology LLC, doing business as Astrix Technology Group. The $97,175.20 firm-fixed-price contract was awarded on November 1, 2021 and has an ultimate completion date of October 30, 2022.
The contract is for Astrix Technology to provide a biologist familiar with the National Cancer Institute's research to independently conduct experiments, present results, and participate in weekly discussions. This contract falls under the National Cancer Institute's Major Program Code for "Scientific Support Services" and is issued as a Blanket Purchase Agreement (BPA) call order under Astrix's existing Multiple Award Schedule (MAS) contract. No set-aside designation is indicated. Astrix Technology has previously provided a range of scientific, research, technical, and administrative support services to various National Institutes of Health (NIH) components to advance biomedical research objectives.
Quick answers
Who was awarded contract 75N91022F00012?
75N91022F00012 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on November 1, 2021.
How much is contract 75N91022F00012 worth?
The government has obligated $97,175 on 75N91022F00012.
Is contract 75N91022F00012 an order under another contract?
Yes. 75N91022F00012 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75N91022F00012 competed?
The extent of competition for 75N91022F00012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award